Compare Enzyme (MLN) vs Obol (OBOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Obol — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Obol trades at Rp157.55 (market cap Rp30,1M, Rp51,72M 24h volume). The key difference: Enzyme is far larger — about 4.5× Obol's market cap, and Obol's supply is capped (161,3M / 500M OBOL (33%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Obol for 14 Days on average.
| MLN | OBOL | |
|---|---|---|
Market Cap | Rp134,13M | Rp30,1M |
Volume (24h) | Rp104,56M | Rp51,72M |
Circulating Supply | 3,3M MLN | 161,3M / 500M OBOL (33%) |
Typical Hold Time | 28 Days | 14 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Obol currently has a market cap of Rp30.1M with a circulating supply of 161.3 million tokens out of a maximum 500 million, indicating 33% circulation. The token exhibits a 14-day average hold time, suggesting moderate short-term holding behavior. No recent price or volume data is available, limiting technical trend analysis. There are no major protocol updates or ecosystem developments reported recently, with network activity appearing subdued.
Outlook remains cautious due to limited data and low market cap, presenting speculative opportunities if ecosystem activity increases. Key risks include extreme volatility, low liquidity, and regulatory uncertainty inherent to small-cap cryptocurrencies. Investors should monitor for new exchange listings or protocol upgrades that could drive adoption.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Obol
Obol develops vital technologies that enhance Ethereum's decentralization and security, currently protecting billions in staked ETH. Its Distributed Validators (DVs) offer better uptime, lower risk, and improved performance compared to traditional staking. Using the middleware Charon, DVs enable Ethereum validators to function across multiple operators and machines, featuring threshold signing and distributed key generation for added resilience. The Obol Collective, powered by the OBOL Token, includes the largest decentralized operator ecosystem with major players like Lido and Blockdaemon. The Obol Stack simplifies the deployment of Ethereum nodes and other decentralized infrastructures, advancing the Ethereum economy.
Read more on OBOL →
